The ethical drug company Novo Nordisk will report earnings on Wednesday, January 31. Analysts expect the company to report EPS of $0.67 on revenue of $8.7 billion. This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Tags:$NVO Share: Mark W. Guthner, CFA Previous Post Economy & the Cost of Government BorrowingNext PostThe Week Ahead | 1/29/2024 You Might Also Like Biotech ETF: XBI February 28, 2024 Honda Motor Corporation: HMC September 21, 2023 Hilton Worldwide (HLT): A Head Shaker February 10, 2021
You Might Also Like Biotech ETF: XBI February 28, 2024 Honda Motor Corporation: HMC September 21, 2023 Hilton Worldwide (HLT): A Head Shaker February 10, 2021
